What Happened
Rajesh Palviya from Axis Securities has issued 'buy' recommendations for Glenmark Pharma, Marico, and SAIL shares on April 24th. This advice comes as the broader Indian market, represented by Nifty 50 and Sensex, experienced its third consecutive day of decline, primarily due to rising oil prices and underperforming IT stocks like Infosys.
Why It Matters (for you)
This is significant for traders as it highlights specific investment opportunities identified by an expert during a period of market correction. While the overall sentiment is bearish, these recommendations suggest that certain stocks or sectors might offer defensive plays or value, potentially decoupling from the broader market trend. It provides a counter-narrative to the prevailing negative sentiment.
Impact on Indian Markets
The recommendations are positive for GLENMARK, MARICO, and SAIL, potentially attracting buying interest and providing some support to their share prices. Conversely, the mention of 'weak IT stocks' and specifically INFY reinforces the negative sentiment for the IT sector, suggesting continued pressure on stocks like TCS, WIPRO, and HCLTECH. The broader market weakness impacts all sectors, but these specific calls offer a nuanced view.
What Traders Should Watch Next
Traders should monitor the performance of the recommended stocks against the broader market trend to see if they indeed show resilience. Also, keep an eye on crude oil prices and global cues, as these are key drivers for the current market weakness. Further analyst reports or company-specific news for GLENMARK, MARICO, and SAIL could provide additional catalysts or risks.
Key Evidence
- Nifty 50 and Sensex fell for the third consecutive session on April 24.
- Market decline was impacted by high oil prices and weak IT stocks, specifically Infosys.
- Rajesh Palviya of Axis Securities suggested Glenmark Pharma, Marico, and SAIL shares to buy.
- The market is down 1.4% and 1.8% weekly, with broad-based selling.
- Risk flag: Regulatory hurdles (USFDA)